0001144204-17-000938.txt : 20170105
0001144204-17-000938.hdr.sgml : 20170105
20170105210016
ACCESSION NUMBER: 0001144204-17-000938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMinn Rachel
CENTRAL INDEX KEY: 0001606302
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 17512693
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 450 W. 15TH ST., STE. 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
4
1
v456333_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-01-03
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001606302
McMinn Rachel
C/O INTERCEPT PHARMACEUTICALS, INC.
450 W. 15TH STREET, SUITE 505
NEW YORK
NY
10011
0
1
0
0
Chief Strategy Officer
Common Stock
2017-01-03
4
S
0
816
103.9191
D
12916
D
Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee.
/s/ Bryan Yoon, as attorney-in-fact
2017-01-05